163 related articles for article (PubMed ID: 8390809)
1. Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.
Rice LB; Carias LL; Etter L; Shlaes DM
Antimicrob Agents Chemother; 1993 May; 37(5):1061-4. PubMed ID: 8390809
[TBL] [Abstract][Full Text] [Related]
2. In vivo efficacies of beta-lactam-beta-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae.
Rice LB; Carias LL; Shlaes DM
Antimicrob Agents Chemother; 1994 Nov; 38(11):2663-4. PubMed ID: 7872765
[TBL] [Abstract][Full Text] [Related]
3. Molecular aspects of high-level resistance to sulbactam-cefoperazone in Klebsiella oxytoca clinical isolates.
Kimura K; Arakawa Y; Ohsuka S; Ito H; Suzuki K; Kurokawa H; Kato N; Ohta M
Antimicrob Agents Chemother; 1996 Sep; 40(9):1988-94. PubMed ID: 8878568
[TBL] [Abstract][Full Text] [Related]
4. The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms.
Chang PC; Chen CC; Lu YC; Lai CC; Huang HL; Chuang YC; Tang HJ
J Microbiol Immunol Infect; 2018 Apr; 51(2):207-213. PubMed ID: 29037802
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.
Rice LB; Yao JD; Klimm K; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1991 Jun; 35(6):1243-4. PubMed ID: 1929273
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
Rice LB; Carias LL; Bonomo RA; Shlaes DM
J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
[TBL] [Abstract][Full Text] [Related]
7. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
Fasola EL; Fasching CE; Peterson LR
J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
[TBL] [Abstract][Full Text] [Related]
8. beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.
Williams JD
Clin Infect Dis; 1997 Mar; 24(3):494-7. PubMed ID: 9114205
[TBL] [Abstract][Full Text] [Related]
9. AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Younas S; Ejaz H; Zafar A; Ejaz A; Saleem R; Javed H
J Pak Med Assoc; 2018 Jun; 68(6):893-897. PubMed ID: 30325907
[TBL] [Abstract][Full Text] [Related]
10. The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
Jones RN; Barry AL; Thornsberry C; Wilson HW
Am J Clin Pathol; 1985 Oct; 84(4):496-504. PubMed ID: 2994461
[TBL] [Abstract][Full Text] [Related]
11. Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.
Thomson KS; Weber DA; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1990 Apr; 34(4):622-7. PubMed ID: 2344169
[TBL] [Abstract][Full Text] [Related]
12. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
[TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.
Caron F; Gutmann L; Bure A; Pangon B; Vallois JM; Pechinot A; Carbon C
Antimicrob Agents Chemother; 1990 Nov; 34(11):2070-4. PubMed ID: 2073099
[TBL] [Abstract][Full Text] [Related]
14. [In vitro susceptibility to cefoperazone and sulbactam/cefoperazone combination of bacterial strains isolated from various patient materials].
Aksoy AM; Ozsan M; Ural O; Ekmen H
Mikrobiyol Bul; 1993 Jul; 27(3):216-20. PubMed ID: 8361410
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of antibiotic resistance and genotypes on extended spectrum β-lactamase and AmpC β-lactamase producing strains isolated from Uygur and Han newborns].
Zhang WL; Liu J; Zhang J; Su GL
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar; 45(3):217-24. PubMed ID: 21624232
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
Kuo HY; Wang FD; Yen YF; Lin ML; Liu CY
New Microbiol; 2009 Jan; 32(1):49-55. PubMed ID: 19382669
[TBL] [Abstract][Full Text] [Related]
17. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
Chambers HF; Fournier MA
J Antimicrob Chemother; 1993 Sep; 32(3):453-8. PubMed ID: 8262867
[TBL] [Abstract][Full Text] [Related]
19. In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone.
Chandrasekar PH; Sluchak JA
Infection; 1991; 19(1):49-53. PubMed ID: 2013510
[TBL] [Abstract][Full Text] [Related]
20. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
Bradford PA; Urban C; Mariano N; Projan SJ; Rahal JJ; Bush K
Antimicrob Agents Chemother; 1997 Mar; 41(3):563-9. PubMed ID: 9055993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
